Self-improving models are reshaping the AI race as OpenAI, Anthropic, Google and others pursue superintelligence.

For the past decade, we’ve been sold a seductive vision: the “smart city.” Gleaming control rooms, traffic lights that talk ...

Alongside this rapid progress, an equally ambitious effort has emerged to construct ethical frameworks for intelligent ...

Amazon Mechanical Turk shutdown ends 21 years of invisible labor that powered the AI training industry, as AWS closes the ...

Background Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disorder lacking a gold-standard diagnostic ...

The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...

OpenAI has talked about how having an automated AI researcher was on its roadmap, and it’s shown the first glimpses of that ...

The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...